Elanco to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference

Rhea-AI Summary

Elanco Animal Health (NYSE: ELAN) announces its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference, scheduled for September 4-5, 2024. The company's President and CEO Jeff Simmons, along with Executive VP and CFO Todd Young, will engage in a fireside chat on Thursday, September 5 at 3:20 p.m. ET.

Investors and interested parties can access a live audio webcast of the session through the "Events and Presentations" section of Elanco's investor website. For those unable to attend live, a replay will be available for approximately 30 days after the event. This conference participation highlights Elanco's commitment to investor relations and provides an opportunity for stakeholders to gain insights into the company's strategies and performance.

News Market Reaction

%

1 alert

% News Effect

On the day this news was published, ELAN declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

GREENFIELD, Ind., Aug. 28, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 22^nd Annual Global Healthcare Conference, September 4-5, 2024. Jeff Simmons, President and CEO, and Todd Young, executive vice president and CFO, will participate in a fireside chat on Thursday, September 5 at 3:20 p.m. ET.

A live audio webcast will be available in the "Events and Presentations" section of Elanco's investor website. A replay will be available for approximately 30 days.

ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose– all to advance the health of animals, people, the planet and our enterprise. Learn more at www.elanco.com.

Investor Contact: Katy Grissom (317) 273-9248 kathryn.grissom@elancoah.com
Media Contact: Colleen Parr Dekker (317) 989-7011 colleen_parr_dekker@elancoah.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/elanco-to-participate-in-morgan-stanley-22nd-annual-global-healthcare-conference-302230737.html

SOURCE Elanco Animal Health

FAQ

When is Elanco (ELAN) participating in the Morgan Stanley Healthcare Conference?

Elanco (ELAN) is participating in the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4-5, 2024. Their fireside chat is scheduled for Thursday, September 5 at 3:20 p.m. ET.

Who will represent Elanco (ELAN) at the Morgan Stanley Healthcare Conference?

Jeff Simmons, President and CEO, and Todd Young, Executive Vice President and CFO, will represent Elanco (ELAN) at the Morgan Stanley Healthcare Conference.

How can investors access Elanco's (ELAN) presentation at the Morgan Stanley conference?

Investors can access a live audio webcast of Elanco's (ELAN) presentation through the "Events and Presentations" section of Elanco's investor website. A replay will be available for about 30 days after the event.

What type of session will Elanco (ELAN) participate in at the Morgan Stanley conference?

Elanco (ELAN) will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference.

How long will the replay of Elanco's (ELAN) Morgan Stanley conference presentation be available?

The replay of Elanco's (ELAN) presentation at the Morgan Stanley conference will be available for approximately 30 days after the event.